Mozambique’s TB/HIV funding request to the Global Fund builds on achievements of current grants, TRP says
Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.
Les cibles nationales ambitieuses de mise sous traitement ne se retrouvent souvent pas dans les cadres de résultats des subventions, selon le CAS
Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says
In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation
Le Mozambique présente au Fonds mondial une demande de financement de 513,1 millions de dollars pour la lutte conjointe contre le VIH et la tuberculose
An audit into grants to Mozambique undertaken by the Office of the Inspector General has concluded that both grant implementation arrangements and supply chain controls and assurance mechanisms “need significant improvement.”
“Needs significant improvement” is the second lowest rating in the OIG’s four tier rating scheme. The four tiers are effective; partially effective; needs significant improvement; and ineffective.
The Board has approved $77 million to extend Mozambique shortened HIV grant (MOZ-H-MOH). The additional funds will allow Mozambique to continue providing services through to the end of 2017. The Board was acting on the recommendations of Technical Review Panel and the Grant Approvals Committee.
Le Conseil approuve un financement pour prolonger la durée de deux subventions raccourcies en RDC et au Mozambique
Pour la première fois, le Conseil a approuvé un financement supplémentaire pour des subventions à la durée raccourcie. La décision a été prise le 14 mars 2016, le jour même que le Conseil a approuvé un financement supplémentaire pour deux subventions TB/VIH pour le Libéria à partir des allocations pour 2014-2016.
Les subventions raccourcies
For the first time, the Board has approved additional funding for two shortened grants. The decision came on 14 March 2016, the same day that that the Board approved additional funding for two TB/HIV grants for Liberia from the 2014-2016 allocations.
Elimination 8 (E8) has set the formidable target of full malaria elimination in Botswana, Namibia, South Africa and Swaziland by 2020. Termed the “frontline four”, these countries are nearing elimination of the disease after achieving a 75% decline between 2000 and 2012.